The 52-week high and low prices can offer valuable insights into a stock’s current standing and prospects for future performance. Macrogenics Inc’s current trading price is -66.86% away from its 52-week high, while its distance from the 52-week low is 70.77%. The stock’s price range for this period has been between $0.99 and $5.10 The company’s shares, which are part of the Healthcare sector, had a trading volume of approximately 1.5 million for the day, a number notably higher than the average daily volume of 1.24 million over the last three months.
At present, Macrogenics Inc (MGNX) has a stock price of $1.69. In the previous session, the stock saw a rise, peaking at $5.0 after an opening price of $1.69. The day’s lowest price was $2.0, and it closed at $1.44.
The market performance of Macrogenics Inc’s stock has been turbulent in recent times. Over the last year, the company’s stock reached its highest point at $5.10 on 11/06/24, while the lowest value for the same duration was $0.99 on 04/07/25.
Exploring Financial Performance and Market Capitalization: A Comprehensive Analysis
Macrogenics Inc (MGNX) has experienced a quarterly rise of 6.96% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 106.82M and boasts a workforce of 341 employees.
Macrogenics Inc: What Analysts Are Saying
As of right now, 1 analyst is rating Macrogenics Inc as a BUY, 1 of the polled analysts branded the stock as an OVERWEIGHT, 5 analysts are recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 analyst is rating the stock as SELL.
Analyzing Trading Volume and Moving Average Trends
Based on Barchart.com data, the company’s moving average over the 100-day period was 1.4900, with a change in price of +0.4200. Similarly, Macrogenics Inc recorded 1,044,079 in trading volume during the last 100 days, posting a change of +33.07%.
Understanding Ticker ‘s Debt-to-Equity Ratio: An Analysis
The debt-to-equity (D/E) ratio serves as an important indicator of a company’s financial stability and market position. By dividing a company’s total liabilities by its shareholders’ equity, the D/E ratio reveals the degree to which a company relies on debt to finance assets compared to its shareholders’ equity. At the time of writing, the total D/E ratio for MGNX stands at 2.31. Similarly, the long-term debt-to-equity ratio is also 2.20.
MGNX Stock Stochastic Average
As of today, Macrogenics Inc’s raw stochastic average for the last 50 days stands at 72.66%. This is a decline compared to the raw stochastic average of the previous 20 days, which was noted at 78.79%. Furthermore, the company’s Stochastic %K and %D values for the past 20 days were 31.66% and 19.02%, respectively.
MGNX Stock Price Performance Analysis
A mixed performance in the stock price over the year has left investors unsure of what to expect, resulting in a range of outlooks from optimistic to pessimistic. Year to date metric has recorded a loss of -53.31%.However, over the last six months, we can see a stronger performance of -38.77%. Over the last 30 days, the price of MGNX has leaped by -5.06%. And in the last five days, it has surged by 6.96%.
